Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies Journal Article

  

Authors:	Burger, J. A.; Cramer, P.; Barr, P. M.; Dilhuydy, M. S.; Mato, A.; Byrd, J. C.; Chang, S.; Graef, T.; Lin, T.; Tedeschi, A.
Article Title:	Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies
Keywords:	survival outcomes; comorbidities; ibrutinib; bruton's tyrosine kinase inhibitor; chronic lymphocytic leukaemia
Journal Title:	British Journal of Haematology
Volume:	186
Issue:	1
ISSN:	0007-1048
Publisher:	John Wiley & Sons
Date Published:	2019-07-01
Start Page:	175
End Page:	180
Language:	English
DOI:	10.1111/bjh.15784
PUBMED:	30739324
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061439213&doi=10.1111%2fbjh.15784&partnerID=40&md5=5d08573f2a808d053d1feeef4f61037c
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/150274